Michael J. Morris

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

89h-index40.0kcitations865works11.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(565), Radiopharmaceutical Chemistry and Applications(300), Prostate Cancer Diagnosis and Treatment(109), Cancer, Lipids, and Metabolism(100), Cancer Genomics and Diagnostics(74)

Publications859 total

Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research·2025Open Access
Association of <scp> <i>SULT2A1</i> </scp> Locus With Abiraterone Clearance in the Alliance <scp>A031201</scp> : Randomized Phase <scp>III</scp> Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration‐Resistant Prostate Cancer
Clinical and Translational Science·2025Open Access
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer
JCO Oncology Practice·2025
Variation in guideline-concordant use of bone modifying agents for prostate cancer.
JCO Oncology Practice·2025
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
European Urology·2025· 7 citedOpen Access
2542eTiP Phase I/II dose escalation and expansion of AB001 in patients with metastatic castration-resistant prostate cancer (mCRPC): The ARTISAN trial
Annals of Oncology·2025
Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions
Current Oncology Reports·2025· 3 cited
Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
Annals of Oncology·2025· 8 citedOpen Access
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research
JCO Oncology Practice·2025
Acupuncture for Nocturia in Survivors of Prostate Cancer
JAMA Oncology·2025· 1 cited
Patient-reported experience with an immunotherapy telehealth platform.
Journal of Clinical Oncology·2025
Trial in progress (XALute): Phase 3 study of xaluritamig vs investigator’s choice of cabazitaxel or second androgen receptor directed therapy (ARDT) in post-taxane metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2025· 2 cited
An oral prostate cancer RIPTACtherapeutic in phase 1 for metastatic castrate resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2025· 1 cited
Ipilimumab and nivolumab in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated on the phase 3 PDIGREE (Alliance A031704) trial: Results from Step 1 analysis.
Journal of Clinical Oncology·2025· 2 cited
A randomized trial of radium-223 dichloride and cabozantinib in patients with advanced renal cell carcinoma (RCC) with osseous metastases (RADICAL/Alliance A031801).
Journal of Clinical Oncology·2025
Pilot study of an enhanced telehealth program for patients with prostate cancer.
Journal of Clinical Oncology·2025· 1 cited
PSMA-delay castration (DC): An open-label, multicenter, randomized phase 3 study of [ <sup>177</sup> Lu]Lu-PSMA-617 versus observation in patients with metachronous PSMA-positive oligometastatic prostate cancer (OMPC).
Journal of Clinical Oncology·2025· 6 cited
Imaging with [ <sup>89</sup> Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with neuroendocrine tumors of the prostate: A phase 1/2, first-in-human trial.
Journal of Clinical Oncology·2025
Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
The Lancet Oncology·2025· 8 citedOpen Access
Mechanisms of the Extreme Wind Speed Response to Climate Change in Variable-Resolution Climate Simulations of Western, Central, and Atlantic Canada
Journal of Climate·2025· 1 citedOpen Access
page 1 of 43Next →

Frequent Co-authors

Howard I. Scher(28), Susan Halabi(12), Philip W. Kantoff(11), Steven M. Larson(11), Johann S. de Bono(10), Eric J. Small(10), Dana E. Rathkopf(9), Susan F. Slovin(9), Anuradha Gopalan(7), Karim Fizazi(7), Charles L. Sawyers(7), Nikolaus Schultz(6), Wassim Abida(6), Tomasz M. Beer(6), Celestia S. Higano(6), William Kevin Kelly(6), Charles J. Ryan(6), Daniel C. Danila(6), Gerhardt Attard(5), Himisha Beltran(5)